Searched for
JEFFERIES RESEARCH REPORT
SpaceX IPO: Why Wall Street biggies Chris Wood, others are not impressed with $1.8 trillion listingDespite significant investor interest, Wall Street experts like Chris Wood and Aswath Damodaran express skepticism over SpaceX's $1.8 trill...- Global Markets: Japan's Nikkei tops 67,000 on AI boost; SoftBank becomes most valuable Japanese firmJapan's Nikkei index reached a historic 67,000 mark. AI stocks powered this surge, with SoftBank Group becoming the nation's most valuable ...
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...
- Market Outlook: US-Iran talks, crude oil among 5 factors to drive D-St in first week of JuneMarkets brace for a crucial week. Investors watch US-Iran peace talks closely. Crude oil price drops also impact sentiment. Foreign investo...
- AI costs spiral as firms lose spending controlCompanies are facing massive AI bills, with one firm reportedly spending $500 million in a month on Claude AI due to unchecked usage. Sever...
- German 10-year bond yield stays at 15-year high amid global bond routGlobal bond markets are experiencing a selloff. Investors are concerned about rising energy prices due to the Middle East conflict. This co...
- ETtech Explainer: Why is Swiggy stock tanking after its Q4 results?Swiggy's stock dipped 7% after reporting a 45% rise in Q4 FY26 revenue to Rs 6,383 crore and a narrowed net loss. Analysts cited a slowdown...
- Uber-backed Lime reveals revenue surge in US IPO filingLime, the electric bike and scooter company, has filed for a U.S. initial public offering. The firm reported a significant increase in year...
- China's open-source AI models challenge US dominance as Europe grapples with Iran fallout: ReportChina's artificial intelligence services are surging, with its models processing vast amounts of data. This growth highlights its expanding...
- Axis Bank slips despite 'Buys' as provisions cast a shadowAxis Bank shares fell 3% despite analysts maintaining a positive outlook, with 94% recommending 'Buy'. The bank's loan growth was strong, b...
- Stock Market Crash Today: D-Street investors lose Rs 5 lakh crore. 7 reasons why Sensex and Nifty fellIndian stock markets experienced sharp losses for the third consecutive session, with Sensex and Nifty falling over 1% each. Escalating Ira...
- Wipro Q4 net profit dips 1.9% to Rs 3,502 crore, revenue rises 8%Wipro reported a 1.6% decline in annual revenue in fiscal year 2026 in constant currency terms, in line with its larger rival, Tata Consult...
- Banks to report steady profit rise as loans grow, treasury dragsIndian banks are expected to report a steady profit rise in the January-March quarter, four brokers said, aided by credit growth and liquid...
- Biggest currency clampdown in decade risks backfiring for IndiaIndia's Reserve Bank of India has intervened to support the rupee, forcing local banks to unwind bearish bets. This move, while strengtheni...
- No windfall tax on diesel, ATF exports from Reliance SEZ: OfficialReliance Industries SEZ refinery will not face new export taxes on diesel and aviation fuel. This exemption stems from judicial pronounceme...
- More missiles or no war? How markets are reading Trump's latest signalsIndian markets plunged Thursday as President Trump's threats of escalating strikes on Iran spooked investors. The Sensex dropped significan...
- US Stock Market | Wall Street indexes fall on worries about Middle East war, interest ratesWall Street indexes experienced volatility as investors weighed rising oil prices against hopes for a U.S.-Iran de-escalation. President Tr...
- 10 CLSA India employees may join Jefferies: ET NOWCLSA analysts Mahesh Nandurkar and Ashish Agrawal are among those employees who are making the switch.
- CLSA’s India division too witnessing an exodusMost of the exits have happened from research, while one is said to be from the sales trading team.
- Indian drug makers need to shift focus to complex therapies than mere launches: JefferiesIndian pharma companies, who have built their revenues by selling generic drugs to developed markets, might have to shift their business st...
Load More
